Group ISS. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;2015:795–807.
Legarth RA, Ahlstrom MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr. 2016;71:213–8.
Cheng W, Tang W, Han Z, Tangthanasup TM, Zhong F, Qin F, et al. Late presentation of HIV infection: prevalence, trends, and the role of HIV testing strategies in Guangzhou, China, 2008-2013. Biomed Res Int. 2016;2016:1631878.
Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, et al. Late presentation into care of HIV disease and its associated factors in Asia: results of TAHOD. AIDS Res Hum Retrovir. 2016;32:255–61.
Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10:e1001510.
Honge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva TD, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. Pan Afr Med J. 2016;25:40.
Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18:2145–51.
Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352–63.
Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175:588–96.
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–50.
Guillon M, Celse M, Geoffard PY. Economic and public health consequences of delayed access to medical care for migrants living with HIV in France. Eur J Health Econ. 2018;19:327–40.
Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, Blaxhult A, et al. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med. 2003;4:255–62.
Centers for Disease Control DoH, R.O.C. (Taiwan). HIV/AIDS. http://www.cdc.gov.tw/english/info.aspx?treeid=e79c7a9e1e9b1cdf&nowtreeid=e02c24f0dacdd729&tid=7D01A79F5FD3B63D. Accessed 10 Nov 2017.
Lin T, Chen CH, Chou P. Effects of combination approach on harm reduction programs: the Taiwan experience. Harm Reduct J. 2016;13:23.
Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med. 2008;9:535–43.
Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Liu CE, et al. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One. 2017;12:e0179870.
Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1992;41.
Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003;22:61–76.
Yen YF, Jen IA, Chen M, Lan YC, Lee CY, Chuang PH, et al. HIV infection increases the risk of incident psoriasis: a nationwide population-based cohort study in Taiwan. J Acquir Immune Defic Syndr. 2017;75:493–9.
Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380:367–77.
Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50:1512–20.
Centers for Disease Control DoH, R.O.C. (Taiwan). Centers for Disease Control Annual Report. http://www.cdc.gov.tw/infectionreport.aspx?nowtreeid=61AB37D12031B95A&treeid=075874DC882A5BFD. Accessed 10 Nov 2017.
Cherutich P, Kaiser R, Galbraith J, Williamson J, Shiraishi RW, Ngare C, et al. Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study. PLoS One. 2012;7:e36797.
Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in cape town, South Africa. Sex Transm Infect. 2003;79:442–7.
Creek TL, Ntumy R, Seipone K, Smith M, Mogodi M, Smit M, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr. 2007;45:102–7.
Centers for Disease Control DoH, R.O.C. (Taiwan). Designated HIV/AIDS Hospitals. https://www.syndriver.com/portal/#/sharing/a725aee3b57145ab822ad96bf77d98bf. Accessed 10 Nov 2017.
O'Connell S, Enkelmann J, Sadlier C, Bergin C. Late HIV presentation - missed opportunities and factors associated with a changing pattern over time. Int J STD AIDS. 2017;28:814–21.
Finlayson TJ, Le B, Smith A, Bowles K, Cribbin M, Miles I, et al. HIV risk, prevention, and testing behaviors among men who have sex with men--national HIV behavioral surveillance system, 21 U.S. cities, United States, 2008. MMWR Surveill Summ. 2011;60:1–34.
Sionean C, Le BC, Hageman K, Oster AM, Wejnert C, Hess KL, et al. HIV risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--national HIV behavioral surveillance system, 21 U.S. cities, 2010. MMWR Surveill Summ. 2014;63:1–39.
Persson A, Brown G, McDonald A, Korner H. Transmission and prevention of HIV among heterosexual populations in Australia. AIDS Educ Prev. 2014;26:245–55.
Robinson WT, Zarwell M, Gruber D. Preferences for home-based HIV testing among heterosexuals at increased risk for HIV/AIDS: New Orleans, Louisiana, 2013. J Acquir Immune Defic Syndr. 2017;75(Suppl 3):S352–6.
Centers for Disease Control DoH, R.O.C. (Taiwan). Centers for Disease Control Annual Report 2017. http://126.96.36.199/uploads/files/201708/00a53329-34ba-4194-97f7-81480c446cbe.pdf. Accessed 10 Nov 2017.
Chen YJ, Lee CM, Chen M, Chuang SY, Liu HF, Wong WW, et al. Molecular epidemiology of HIV-1 infection in Taiwan from 2005 to 2008: further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection. J Acquir Immune Defic Syndr. 2012;59:438–46.
Lin PH, Lai CC, Yang JL, Huang HL, Huang MS, Tsai MS, et al. Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users. Emerg Microbes Infect. 2013;2:e83.
Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005. Int J Drug Policy. 2008;19:317–23.
Camoni L, Raimondo M, Regine V, Salfa MC, Suligoi B. Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011. BMC Public Health. 2013;13:281.
Ward EG, Disch WB, Schensul JJ, Levy JA. Understanding low-income, minority older adult self-perceptions of HIV risk. J Assoc Nurses AIDS Care. 2011;22:26–37.
Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis. 1999;28:740–5.
Zingmond DS, Kilbourne AM, Justice AC, Wenger NS, Rodriguez-Barradas M, Rabeneck L, et al. Differences in symptom expression in older HIV-positive patients: the veterans aging cohort 3 site study and HIV cost and service utilization study experience. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S84–92.
Illa L, Brickman A, Saint-Jean G, Echenique M, Metsch L, Eisdorfer C, et al. Sexual risk behaviors in late middle age and older HIV seropositive adults. AIDS Behav. 2008;12:935–42.
Sood N, Wagner Z, Jaycocks A, Drabo E, Vardavas R. Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County. Clin Infect Dis. 2013;56:1789–96.
Seth P, Wang G, Collins NT, Belcher L. Identifying new positives and linkage to HIV medical care--23 testing site types, United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:663–7.
Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17. quiz CE11-14
Leitinger D, Ryan KE, Brown G, Pedrana A, Wilkinson AL, Ryan C, et al. Acceptability and HIV prevention benefits of a peer-based model of rapid point of care HIV testing for Australian gay, bisexual and other men who have sex with men. AIDS Behav. 2018;22:178–89.
Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD. The case for indicator condition-guided HIV screening. HIV Med. 2013;14:445–8.
Klein D, Hurley LB, Merrill D, Quesenberry CP Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003;32:143–52.
Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care. 2017;29:489–97.
Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, et al. Sex, race, and HIV risk disparities in discontinuity of HIV care after antiretroviral therapy initiation in the United States and Canada. AIDS Patient Care STDs. 2017;31:129–44.
Bitew BD, Berehane Y, Getahun E, Abyu D. Determinants of none-adherence to antiretroviral therapy among HIV-infected adults in Arba Minch General Hospital, Gamo Gofa Zone, Southern Ethiopia: a case control study. Am J Health Res. 2014;2:234–40.
Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7:e35547.
Ferro EG, Culbert GJ, Wickersham JA, Marcus R, Steffen AD, Pauls HA, et al. Physician decisions to defer antiretroviral therapy in key populations: implications for reducing human immunodeficiency virus incidence and mortality in Malaysia. Open Forum Infect Dis. 2017;4:ofw219.
Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105:e5–16.
Kouyoumdjian FG, McIsaac KE, Liauw J, Green S, Karachiwalla F, Siu W, et al. A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after release. Am J Public Health. 2015;105:e13–33.
Sharif MR, Chitsazian Z, Moosavian M, Raygan F, Nikoueinejad H, Sharif AR, et al. Immune disorders in hemodialysis patients. Iran J Kidney Dis. 2015;9:84–96.
El Amrani M, Asserraji M, Bahadi A, El Kabbaj D, Benyahia M. Tuberculosis in hemodialysis. Medecine et Sante Tropicales. 2016;26:262–6.
Inaba A, Okada A, Yoshida T, Itoyama S, Nakai T, Hisada T, et al. Disseminated Cryptococcosis with rapidly growing lung nodules in an end-stage renal disease patient. Intern Med. 2017;56:377–80.
Mansouri L, Paulsson JM, Moshfegh A, Jacobson SH, Lundahl J. Leukocyte proliferation and immune modulator production in patients with chronic kidney disease. PLoS One. 2013;8:e73141.